JP3173317U - Pharmaceutical model - Google Patents

Abstract

Provided is a pharmaceutical model that is excellent in safety without affecting the human body even if a user accidentally eats a dummy pharmaceutical product of the pharmaceutical model.
SOLUTION: Provided for sales promotion with a dummy dummy drug 2 that does not contain an active ingredient as a drug, an outer case 3 for packaging the dummy drug 2, and a label 4 arranged in the case 3 A pharmaceutical model 1 is constructed. Moreover, the said dummy pharmaceutical 2 consists of an edible component which does not affect a human body even if a user eats.
[Selection] Figure 1

Description

  The present invention relates to a pharmaceutical model, and more particularly, to a pharmaceutical model that is excellent in safety without affecting the human body even if the user accidentally eats the dummy pharmaceutical product of the pharmaceutical model.

  Conventionally, various types of models (samples) have been manufactured for the purpose of sales promotion for foods eaten by users (generals) and used in stores and sales.

  For example, Japanese Utility Model Laid-Open No. 5-79582 (Patent Document 1) discloses a liquid contained in a container, a modeling material provided at or below the liquid surface of the liquid, and the liquid surface or liquid surface. There is disclosed a food sample with an air bubble generating function, which is provided with a foam capable of ejecting gas and a gas supply means connected to the foam. This makes it possible to dynamically express the state that the soup of the stewed food boils and foams, and conveys a sense that is very close to the actual food and beverage to the person who sees the food sample, thereby promoting appetite. It is possible to obtain effects such as

  Japanese Patent Laid-Open No. 6-149156 (Patent Document 2) discloses a food / drink utensil to which a part of a pseudo food is fixed, a lifting / lowering device for raising / lowering the food / drink and a mist from water by ultrasonic vibration. There is disclosed a food model comprising a mist generating device for discharging the mist from the pseudo food. Thereby, it is said that it becomes possible to provide a food model that can actively advertise cooked foods with a simple structure.

  In addition, Japanese Utility Model Registration No. 3032543 (Patent Document 3) discloses a food product model used as a display sample. The food product model is a food product model suitable for use in a high-temperature atmosphere, which is made of porcelain clay as a main raw material, molded into a product shape, fired at low temperature, and the surface of the product is glazed. As a result, there is no seto feeling as in the case of high-temperature firing, and the appearance of Thai and rotary firing can be expressed faithfully.

  In addition, Japanese Utility Model Registration No. 3087569 (Patent Document 4) discloses a food sample model in which a sheet on which an image is formed is attached to a three-dimensional food sample model material shaped like food. As a result, food sample models can be obtained in a short time with high productivity and the same color between models.

  Japanese Patent Laying-Open No. 2005-4171 (Patent Document 5) discloses a food sample having a film portion for displaying an image. The food sample has a shape in which the shape of the film portion is shaped like the apparent outer edge of the food and / or food container. As a result, unlike conventional photographic panels, individual foods are made independent, compact and lightweight, and provided with a three-dimensional shape, so that it is possible to obtain the effect that large installation work is unnecessary Yes.

Japanese Utility Model Publication No. 5-79582 JP-A-6-149156 JP-A-6-149156 Utility Model Registration No. 3087569 Japanese Patent Laying-Open No. 2005-4171

  By the way, among the above-described models, there is a model (medicine model) for promoting the sales of medicines eaten by the user. This pharmaceutical model is composed of, for example, a plastic sheet in which a pellet-shaped dummy pharmaceutical product (simulated pharmaceutical product, drug, tablet) is packaged.

  In consideration of the above-described model (sample) and the fact that the active ingredient of the dummy drug is expensive, the dummy drug can usually be eaten by a user such as an inexpensive plastic. It consists of no inedible ingredients (materials).

  However, since the dummy drug is a very small pellet-like lump, the user can see at a glance whether the dummy drug is a real drug containing an active ingredient or a drug (simulated product) of the inedible ingredient. There is a fact that it cannot be judged. Therefore, there is a problem that a user who has received the drug model for sales promotion misunderstands (misidentifies) the drug model as a real drug and eats the dummy drug. As described above, since the dummy drug is usually composed of inedible components, there is a risk of harming the user who ate the dummy drug.

  Therefore, the present invention has been made to solve the above problems, and even if a user accidentally eats the dummy drug of the drug model, the drug model has no safety and does not affect the human body. The purpose is to provide.

  In order to solve the above-described problems and achieve the object, the pharmaceutical model according to the present invention includes a dummy dummy drug containing no active ingredient as a drug, an outer case for packaging the dummy drug, and a case inside the case. A pharmaceutical model provided for sales promotion, which is composed of arranged labels, and adopts the following configuration.

  That is, the drug model is characterized in that the dummy drug is composed of an edible component that does not affect the human body even if a user eats it.

  According to the pharmaceutical model according to the present invention, even if the user accidentally eats the dummy pharmaceutical product of the pharmaceutical model, it is possible to provide a pharmaceutical model that is excellent in safety without affecting the human body.

It is the schematic block diagram which showed an example of the pharmaceutical model which concerns on this invention. It is the exploded view which showed an example of the pharmaceutical model which concerns on this invention.

  Below, with reference to an accompanying drawing, an embodiment of a pharmaceutical model concerning the present invention is described, and it serves for an understanding of the present invention. In addition, the following embodiment is an example which actualized this invention, Comprising: The thing of the character which limits the technical scope of this invention is not.

  FIG. 1 is a schematic configuration diagram showing an example of a pharmaceutical model according to the present invention. FIG. 2 is an exploded view showing an example of a pharmaceutical model according to the present invention.

  The pharmaceutical model 1 according to the present invention is mainly a pharmaceutical model provided for sales promotion, and as shown in FIG. 1 and FIG. 2, a dummy dummy drug 2 containing no active ingredient as a pharmaceutical, It is composed of an outer case 3 for packaging the dummy medicine 2 and a label 4 arranged in the case 3.

  Here, the said dummy pharmaceutical 2 is comprised from the edible component which does not affect a human body even if a user eats.

  Thereby, even if the user who received the pharmaceutical model 1 accidentally eats the dummy pharmaceutical product 2 of the pharmaceutical model 1, the human body is not affected. Therefore, the pharmaceutical model 1 according to the present invention is extremely excellent in safety.

  In particular, since both the dummy drug 2 and the genuine drug (genuine) drug in the drug model 1 are very small pellet-like lumps, the appearances of both are very similar, and the user should judge at a glance. I can't. In the current aging society, for example, there are many cases where an elderly person accidentally eats the dummy drug 2 in the drug model 1.

  In the present invention, the above-mentioned problems can be solved by configuring the dummy pharmaceutical product 2 of the pharmaceutical model 1 from edible components.

  Here, the edible component in the dummy drug 2 may be any component as long as it is a component that does not affect the human body even if a user eats it. For example, lactose, crystalline cellulose, Examples include a combination of tall, finely divided silicon oxide, sucrose fatty acid ester, calcium stearate, riboflavin, and safflower red pigment. Of these components, the dummy pharmaceutical product 2 may be constituted with a predetermined component as a single component, or a predetermined edible coloring component may be added.

  Moreover, the said dummy pharmaceutical 2 is a pellet form, for example, as shown in FIG. 1, FIG. The number of the dummy medicines 2 is not particularly limited in order to correspond to the real medicines to be sold, but is set to two as shown in FIGS. 1 and 2, for example. Furthermore, each dummy pharmaceutical 2 may be comprised by different types (for example, two types), such as a white tablet and a pink tablet, or a white tablet and a yellow tablet, and may be comprised by the same kind.

  By the way, the case 3 for packaging the dummy medicine 2 is not particularly limited. For example, as shown in FIGS. 1 and 2, the case 3 includes an upper case 3a and a lower case 3b. The upper case 3a includes an inclusion 3a1 that covers most of the dummy drug 2 and has an opening in the lower part, corresponding to the shape and number of the dummy drug 2. The lower case 3b includes a mounting portion 3b1 to which the peripheral end portion of the upper case 3a can be mounted. The mounting portion 3b1 can insert the label 4 together with the peripheral end portion 3a2 of the upper case 3a. A space is provided in advance. Thereby, it becomes possible to wrap the dummy medicine 2 and the label 4 in the case 3.

  Specifically, as shown in FIG. 2, the dummy medicine 2 is placed in the inclusion part 3 a 1 of the upper case 3 a according to the case 3, and the opening of the inclusion part 3 a 1 is covered with the label 4. Next, the peripheral end 3a2 of the upper case 3a and the label 4 are mounted on the mounting portion 3b1 of the lower case 3b, and the upper case 3a and the lower case 3b are overlapped. Thereby, the dummy medicine 2 and the label 4 are packaged in the case 3.

  The label 4 is not particularly limited. For example, as shown in FIGS. 1 and 2, the label 4 is formed of a rectangular sheet that can be fitted to the bottom surface of the mounting portion 3b1 of the lower case. When the material of the label 4 is, for example, paper, plastic, or the like, and the pharmaceutical model 1 according to the present invention is actually transferred to the user, for example, the label 4 is labeled with the pharmaceutical model 1. The name of the corresponding genuine drug, the active ingredient of the drug, the manufacturer, the distributor, etc. are recorded in advance.

  The label 4 is preferably provided with a recess 4a corresponding to the position where the dummy drug 2 is disposed, so that when the dummy drug 2 is disposed, the dummy drug 2 is less likely to be displaced. .

  The pharmaceutical model 1 according to the present invention has a strip shape as shown in FIGS. 1 and 2, but is not particularly limited to this shape, and the design can be changed as appropriate. is there.

  As described above, the pharmaceutical model according to the present invention is useful for a pharmaceutical model for sales purposes such as sales promotion and over-the-counter sales, and even if the user accidentally eats the dummy pharmaceutical product of the pharmaceutical model, It is effective as a pharmaceutical model with no influence and excellent safety.

1 drug model 2 dummy drug 3 case 4 label

Claims (1)

A pharmaceutical model provided for sales promotion, consisting of a dummy dummy drug containing no active ingredients as a drug, an outer case that wraps the dummy drug, and a label placed in the case. There,
A drug model, wherein the dummy drug is composed of an edible component that does not affect the human body even if a user eats it.